Gyroscope Therapeutics
Hannah Beadsmoore is a scientist currently employed at Achilles Therapeutics plc since March 2024. Prior to this role, Hannah served as Research Scientist II at Gyroscope Therapeutics from January 2023 to March 2024. Hannah's earlier experience includes a position as Assay Development Scientist and Assay Development Technician at FLEET BIOPROCESSING LIMITED from August 2020 to January 2023. Hannah holds a Bachelor's degree in Biochemistry from the University of Exeter, which was obtained between 2017 and 2020.
This person is not in any offices
Gyroscope Therapeutics
Gyroscope Therapeutics is a clinical-stage retinal gene therapy company developing gene therapy beyond rare diseases to treat a leading cause of blindness, dry age-related macular degeneration (AMD).